Steve Potts is the founder of Breakthru Medicine. Breakthru Medicine has raised $60M in total funding. Latest round: Series A.
Steve Potts is the Co-Founder and CEO of Breakthru Medicine, an IND-stage biotech company in Phoenix, Arizona focused on cancer drug development. He has a track record of multiple FDA-approved drugs including founding OncoMyx where he raised $75M in venture funding. Recently, he closed Breakthru Medicine's $60M Series A round.
Full founder directory · Investor directory · Company funding database · Fundraising library